SunTrust Banks Analysts Raise Earnings Estimates for Bristol-Myers Squibb Company (BMY)

Modesto Morganelli
Ottobre 22, 2017

Stockholders of record on Friday, October 6th will be given a dividend of $0.39 per share. With 243,500 avg volume, 28 days are for Gildan Activewear Incorporated (NYSE:GIL)'s short sellers to cover GIL's short positions. About 740,905 shares traded or 71.47% up from the average. Gildan Activewear Inc (USA) (NYSE:GIL) has declined 3.41% since October 21, 2016 and is downtrending. It has underperformed by 28.66% the S&P500.

Fulton Breakefield Broenniman Llc increased Bmy (BMY) stake by 10.02% reported in 2017Q2 SEC filing. Plante Moran Financial Advisors Llc sold 10,007 shares as Bristol (BMY)'s stock declined 1.04%. The Cadinha & Co Llc holds 15,760 shares with $878,000 value, up from 4,365 last quarter. Shayne & CO. LLC increased its position in shares of Bristol-Myers Squibb by 0.6% during the second quarter. The stock increased 0.19% or $0.05 on October 19, reaching $27.04. About 734,533 shares traded or 5.16% up from the average.

Shares of Bristol-Myers Squibb Company (NYSE BMY) opened at 64.42 on Friday. It has underperformed by 39.89% the S&P500. Finally, Vetr upgraded shares of Bristol-Myers Squibb from a "buy" rating to a "strong-buy" rating and set a $62.23 price target on the stock in a report on Wednesday, July 12th. Therefore 8% are positive.

Analysts await Concho Resources Inc (NYSE:CXO) to report earnings on October, 31 after the close. The firm has "Outperform" rating by RBC Capital Markets given on Thursday, February 25. The rating was downgraded by CLSA to "Outperform" on Friday, July 7. The stock has a consensus rating of "Hold" and a consensus target price of $63.79. The stock has "Buy" rating by Citigroup on Tuesday, September 20. The rating was maintained by Canaccord Genuity with "Hold" on Friday, November 11. The rating was maintained by Robert W. Baird with "Outperform" on Tuesday, March 22. After $0.74 actual EPS reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts 1.35 % EPS growth. Pointstate Capital Limited Partnership reported 2.16M shares. As per Monday, August 24, the company rating was upgraded by Piper Jaffray.

Gildan Activewear a manufacturer and marketer of branded basic family apparel, including T-shirts, fleece, sport shirts, underwear, socks, hosiery and shapewear. The company has market cap of $2.94 billion. The Firm operates through two divisions: Printwear and Branded Apparel. It has a 14.56 P/E ratio. Moreover, Private Harbour Invest Mgmt Counsel Ltd Liability Corp has 1.03% invested in Bristol-Myers Squibb Co (NYSE:BMY). Therefore 26% are positive. Facebook had 187 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, December 1 the stock rating was maintained by Barclays Capital with "Equal Weight".

More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: which released: "Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company ..." on October 18, 2017, also with their article: "Bristol-Myers Squibb Co (BMY) Stock Raised to Hold" published on October 06, 2017, published: "Bristol-Myers Squibb Co (BMY) Ranking Raised to Buy on Superior Earnings ..." on October 20, 2017. SunTrust maintained it with "Neutral" rating and $20 target in Thursday, September 1 report. The firm has "Buy" rating by Jefferies given on Monday, January 18. One analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the stock. The correct version of this story can be read at Elm Advisors Limited Liability Co reported 0.32% in Bristol-Myers Squibb Co (NYSE:BMY). Welch Investments LLC raised its position in Bristol-Myers Squibb by 3.9% during the 1st quarter. They expect $0.75 earnings per share, down 2.60% or $0.02 from last year's $0.77 per share. The stock has a market capitalization of $106.05 billion, a PE ratio of 23.62 and a beta of 1.19.

In related news, SVP Joseph C. Caldarella sold 9,340 shares of Bristol-Myers Squibb stock in a transaction dated Wednesday, September 6th. Its down 0.03, from 0.98 in 2017Q1. A statistical measure of the dispersion of returns (volatility) for BMY producing salvation in Investors mouth, it has week volatility of 1.82% and for the month booked as 1.34%. 120 funds opened positions while 451 raised stakes. (NYSE:BXS). Quantbot Lp holds 855 shares or 0% of its portfolio. Nadler Fincl Gru reported 6,629 shares. Grassi Invest has 0.8% invested in Bristol-Myers Squibb Co (NYSE:BMY). Moreover, Charter Tru has 0.26% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 39,436 shares. Howard Management invested in 1.5% or 171,201 shares. Douglass Winthrop Advsrs Lc, a New York-based fund reported 41,709 shares. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has "Buy" rating given on Friday, January 22 by Berenberg. Shell Asset Mngmt accumulated 206,295 shares. Fdx Advsr invested 0.06% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Cibc has 446,095 shares. If the published price targets set by Bristol-Myers Squibb Company analysts have any power to influence the stock's share price, the highest price target set for BMY is $75. The biopharmaceutical company reported $0.74 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.73 by $0.01. It worsened, as 48 investors sold CXO shares while 147 reduced holdings. Harvey Cap Management Incorporated holds 0.1% or 2,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE